COVID-19 Rapid Test Kits Partnership Opportunity to offer COVID-19 rapid antibody test kits to retired NFL players through a partnership with the NFL Alumni Association.
Funding for Research Received a $1 million grant for research in collaboration with OncoHost, indicating potential for further funded projects with partners.
High-Density Antibody Array Launch Recently launched a 2000 target antibody array with benefits highlighted in 'The Scientist,' presenting an opportunity for biomarker discovery collaborations.
ELISA Test Technology Breakthrough Announced a new ELISA test technology breakthrough, creating potential for partnerships with institutions and researchers seeking advanced diagnostic solutions.
Market Expansion and Revenue Growth With a revenue range of $10-50 million and global presence, there is room for further expansion by offering innovative proteomic discovery tools to new markets.
$1B
$100M$1B
$100M$1B
$1B
$1B
$1BRayBiotech uses 8 technology products and services including Cloudflare CDN, Cloudflare, WordPress, and more. Explore RayBiotech's tech stack below.
| RayBiotech Email Formats | Percentage |
| First.Last@raybiotech.com | 48% |
| First@raybiotech.com | 31% |
| FLast@raybiotech.com | 18% |
| Last@raybiotech.com | 3% |
Biotechnology ResearchGeorgia, United States51-200 Employees
RayBiotech is a leading life sciences company providing proteomic discovery tools to scientists in 85 countries worldwide. RayBiotech is committed to accelerating research through innovation, leadership, and excellent products and service.
Company Overview
Funding & FinancialsRayBiotech's revenue is in the range of $10M$50M
Funding & FinancialsRayBiotech's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com